Endometriosis Trial, Recruiting NCT07004959 Sponsor: Assistance Publique Hopitaux De Marseille Condition: Endometriosis
Back to Endometriosis

Endometriosis Trial, Recruiting

NCT07004959
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You are between 18 and 45 years old
  • You have been diagnosed with an endometrioma (a type of ovarian cyst linked to endometriosis) confirmed by an internal ultrasound or MRI scan, with a typical appearance, and the cyst measures between 3 and 10 centimetres at its widest point
  • You experience pain related to endometriosis — such as painful periods or ongoing pelvic pain — that you would rate above 30 out of 100 when thinking about the past 4 weeks

Who may not be able to join:

  • You are not able to speak French
  • You do not wish to take part in the study
  • Your ovarian reserve (the number of eggs remaining) is already considered low, based on specific blood or ultrasound measurements (confirm with trial site)
  • You have endometriomas on both ovaries, or two or more cysts larger than 3 centimetres
  • You have previously had surgery to remove an ovarian cyst
  • You have previously had major abdominal surgery that caused scar tissue (adhesions) to form
  • You have an allergy to ethanol (alcohol), as this is used in the treatment being studied
  • You have a medical reason that prevents you from safely having a general anaesthetic
  • You are currently pregnant, in labour, or breastfeeding

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 28 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Antoine NETTER, Assistance Publique - Hôpitaux de Marseille

Phone: 0491382183

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
19 November 2024
Est. completion
19 March 2028

Where this trial is recruiting

🇫🇷 France

Primary endpoints

Difference in the number of millimetres of VAS for pain between the preoperative consultation and the consultation one year after the operation

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov